Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: SOP for Drug Metabolism

SOP for Using Computational Tools for Target Pathway Analysis

Posted on By

SOP for Using Computational Tools for Target Pathway Analysis Standard Operating Procedure (SOP) for Using Computational Tools for Target Pathway Analysis 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the use of computational tools in the analysis of target pathways during drug discovery. Understanding the molecular pathways and interactions involved…

Read More “SOP for Using Computational Tools for Target Pathway Analysis” »

Drug Discovery

SOP for High-Content Screening Methods

Posted on By

SOP for High-Content Screening Methods Standard Operating Procedure (SOP) for High-Content Screening Methods 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting high-content screening (HCS) methods in drug discovery. HCS is a powerful technique that allows for the simultaneous measurement of multiple cellular events, providing comprehensive insights…

Read More “SOP for High-Content Screening Methods” »

Drug Discovery

SOP for Screening Enzyme Inhibitors

Posted on By

SOP for Screening Enzyme Inhibitors Standard Operating Procedure (SOP) for Screening Enzyme Inhibitors 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for screening enzyme inhibitors in drug discovery. Enzyme inhibitors are crucial tools in developing therapeutic agents for diseases where enzymes play a key role in disease progression….

Read More “SOP for Screening Enzyme Inhibitors” »

Drug Discovery

SOP for Early-Stage Biomarker Identification

Posted on By

SOP for Early-Stage Biomarker Identification Standard Operating Procedure (SOP) for Early-Stage Biomarker Identification 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to describe the process of identifying early-stage biomarkers in drug discovery. Biomarkers are biological molecules or indicators that provide insight into disease progression, drug efficacy, and safety. Early-stage biomarker identification plays…

Read More “SOP for Early-Stage Biomarker Identification” »

Drug Discovery

SOP for Preclinical Efficacy Studies Using Cell Lines

Posted on By

SOP for Preclinical Efficacy Studies Using Cell Lines Standard Operating Procedure (SOP) for Preclinical Efficacy Studies Using Cell Lines 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting preclinical efficacy studies using cell lines in drug development. Preclinical efficacy studies assess the biological activity and potential therapeutic…

Read More “SOP for Preclinical Efficacy Studies Using Cell Lines” »

Drug Discovery

SOP for Preparing Target Binding Affinity Reports

Posted on By

SOP for Preparing Target Binding Affinity Reports Standard Operating Procedure (SOP) for Preparing Target Binding Affinity Reports 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process of preparing binding affinity reports for drug discovery studies. Binding affinity reports provide critical information on the strength and specificity of interactions between…

Read More “SOP for Preparing Target Binding Affinity Reports” »

Drug Discovery

SOP for Molecular Dynamics Simulations

Posted on By

SOP for Molecular Dynamics Simulations Standard Operating Procedure (SOP) for Molecular Dynamics Simulations 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for performing Molecular Dynamics (MD) simulations in drug discovery. MD simulations provide a detailed, time-resolved view of molecular motion, helping to understand protein-ligand interactions, stability, conformational changes,…

Read More “SOP for Molecular Dynamics Simulations” »

Drug Discovery

SOP for Cryo-EM Studies in Drug Development

Posted on By

SOP for Cryo-EM Studies in Drug Development Standard Operating Procedure (SOP) for Cryo-EM Studies in Drug Development 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to describe the process of using Cryo-Electron Microscopy (Cryo-EM) for studying biomolecular structures in drug development. Cryo-EM is a powerful technique for determining the three-dimensional structures of…

Read More “SOP for Cryo-EM Studies in Drug Development” »

Drug Discovery

SOP for NMR Spectroscopy for Structure Elucidation

Posted on By

SOP for NMR Spectroscopy for Structure Elucidation Standard Operating Procedure (SOP) for NMR Spectroscopy for Structure Elucidation 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to describe the process of using Nuclear Magnetic Resonance (NMR) spectroscopy to determine the three-dimensional structure of biomolecules and drug candidates in solution. NMR spectroscopy is a…

Read More “SOP for NMR Spectroscopy for Structure Elucidation” »

Drug Discovery

SOP for X-Ray Crystallography in Drug Discovery

Posted on By

SOP for X-Ray Crystallography in Drug Discovery Standard Operating Procedure (SOP) for X-Ray Crystallography in Drug Discovery 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to describe the process of using X-ray crystallography for determining the three-dimensional structure of biomolecules, such as proteins, nucleic acids, and their complexes with drug candidates. X-ray…

Read More “SOP for X-Ray Crystallography in Drug Discovery” »

Drug Discovery

Posts pagination

Previous 1 … 11 12 13 … 16 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme